Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome

Journal of Neuroscience

Volumn 33, Issue 34, 2013, Pages 13612-13620

  Garg, Saurabh K ^a   Lioy, Daniel T ^a   Cheval, Hélène ^b   McGann, James C ^a   Bissonnette, John M ^a,c   Murtha, Matthew J ^e   Foust, Kevin D ^d   Kaspar, Brian K ^e   Bird, Adrian ^b   Mandel, Gail ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; METHYL CPG BINDING PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BREATHING; CONTROLLED STUDY; FEMALE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECOGNITION; RETT SYNDROME; ROTAROD TEST; SCORING SYSTEM; SURVIVAL; VIRAL GENE THERAPY;

ANIMALS; BEHAVIOR, ANIMAL; CELL COUNT; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; MALE; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; MUTATION; NEUROGLIA; NEURONS; PHOSPHOPYRUVATE HYDRATASE; PLETHYSMOGRAPHY; POSTURAL BALANCE; RECOGNITION (PSYCHOLOGY); RESPIRATION; RETT SYNDROME; ROTAROD PERFORMANCE TEST;

EID: 84882718651     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1854-13.2013     Document Type: Article

References (41)

1. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23:185-188.
2. Armstrong DD (2005) Neuropathology of Rett syndrome. J Child Neurol 20:747-753.
3. Ayuso E, Mingozzi F, Montane J, Leon X, Anguela XM, Haurigot V, Edmonson SA, Africa L, Zhou S, High KA, Bosch F, Wright JF (2010) High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency. Gene Ther 17:503-510.
4. Ballas N, Lioy DT, Grunseich C, Mandel G (2009) Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat Neurosci 12:311-317.
5. Chahrour M, Zoghbi HY (2007) The story of Rett syndrome: from clinic to neurobiology. Neuron 56:422-437.
6. Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320:1224-1229.
7. Chen RZ, Akbarian S, Tudor M, Jaenisch R (2001) Deficiency of methyl-CpG binding protein-2 inCNS neurons resultsina Rett-like phenotype in mice. Nat Genet 27:327-331.
8. Cheval H, Guy J, Merusi C, De Sousa D, Selfridge J, Bird A (2012) Postnatal inactivation reveals enhanced requirement for MeCP2atdistinct age windows. Hum Mol Genet 21:3806-3814.
9. Ciesielska A, Hadaczek P, Mittermeyer G, Zhou S, Wright JF, Bankiewicz KS, Forsayeth J (2013) Cerebral infusion of AAV9 vector-encoding non-self proteins can elicit cell-mediated immune responses. Mol Ther 21:158-166.
10. Colantuoni C, Jeon OH, Hyder K, Chenchik A, Khimani AH, Narayanan V, Hoffman EP, Kaufmann WE, Naidu S, Pevsner J (2001) Gene expression profiling in postmortem Rett Syndrome brain: differential gene expression and patient classification. Neurobiol Dis 8:847-865.
11. De Felice C, Guazzi G, Rossi M, Ciccoli L, Signorini C, Leoncini S, Tonni G, Latini G, Valacchi G, Hayek J (2010) Unrecognized lung disease in classic Rett syndrome: a physiologic and high-resolution CT imaging study. Chest 138:386-392.
12. del Gaudio D, Fang P, Scaglia F, Ward PA, Craigen WJ, Glaze DG, Neul JL, Patel A, Lee JA, Irons M, Berry SA, Pursley AA, Grebe TA, Freedenberg D, Martin RA, Hsich GE, Khera JR, Friedman NR, Zoghbi HY, Eng CM, Lupski JR, Beaudet AL, Cheung SW, Roa BB (2006) Increased MECP2 gene copy number as the result of genomic duplication in neurodevelop-mentally delayed males. Genet Med 8:784-792.
13. Derecki NC, Cronk JC, Lu Z, Xu E, Abbott SB, Guyenet PG, Kipnis J (2012) Wild-type microglia arrest pathologyinamouse modelof Rett syndrome. Nature 484:105-109.
14. Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, Kaspar BK (2009) Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol 27:59-65.
15. Friez MJ, Jones JR, Clarkson K, Lubs H, Abuelo D, Bier JA, Pai S, Simensen R, Williams C, Giampietro PF, Schwartz CE, Stevenson RE (2006) Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28. Pediatrics 118:e1687-1695.
16. Fu H, Muenzer J, Samulski RJ, Breese G, Sifford J, Zeng X, McCarty DM (2003) Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene ex pression in mouse brain. Mol Ther 8:911-917.
17. Gadalla KK, Bailey ME, Spike RC, Ross PD, Woodard KT, Kalburgi SN, Bachaboina L, Deng JV, West AE, Samulski RJ, Gray SJ, Cobb SR (2013) Improved survival and reduced phenotypic severity following AAV9/ MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice. Mol Ther 21:18-30.
18. Gao G, Vandenberghe LH, Alvira MR, Lu Y, Calcedo R, Zhou X, Wilson JM (2004) Clades of Adeno-associated viruses are widely disseminated in human tissues. J Virol 78:6381-6388.
19. Grady RM, Wozniak DF, Ohlemiller KK, Sanes JR (2006) Cerebellar synap-tic defects and abnormal motor behavior in mice lacking alpha- and beta-dystrobrevin. J Neurosci 26:2841-2851.
20. Gray SJ, Matagne V, Bachaboina L, Yadav S, Ojeda SR, Samulski RJ (2011) Preclinical differencesof intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates. Mol Ther 19:1058-1069.
21. Guy J, Hendrich B, Holmes M, Martin JE, Bird A (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27:322-326.
22. Guy J, Gan J, Selfridge J, Cobb S, Bird A (2007) Reversal of neurological defects in a mouse model of Rett syndrome. Science 315:1143-1147.
23. Guy J, Cheval H, Selfridge J, Bird A (2011) The role of MeCP2 in the brain. Annu Rev Cell Dev Biol 27:631-652.
24. Hofstaetter JG, Roetzer KM, Krepler P, Nawrot-Wawrzyniak K, Schwarz-braun T, Klaushofer K, Roschger P (2010) Altered bone matrix mineralization in a patient with Rett syndrome. Bone 47:701-705.
25. Jarvik JW, Telmer CA (1998) Epitope tagging. Annu Rev Genet 32:601-618.
26. Lioy DT, Garg SK, Monaghan CE, Raber J, Foust KD, Kaspar BK, Hirrlinger PG, Kirchhoff F, Bissonnette JM, Ballas N, Mandel G (2011) A role for glia in the progression of Rett's syndrome. Nature 475:497-500.
27. McClements ME, MacLaren RE (2013) Gene therapy for retinal disease. Transl Res 161:241-254.
28. McGraw CM, Samaco RC, Zoghbi HY (2011) Adult neural function requires MeCP2. Science 333:186.
29. Motil KJ, Caeg E, Barrish JO, Geerts S, Lane JB, Percy AK, Annese F, McNair L, Skinner SA, Lee HS, Neul JL, Glaze DG (2012) Gastrointestinal and nutritional problems occur frequently throughout lifein girls and women with Rett syndrome. J Pediatr Gastroenterol Nutr 55:292-298.
30. Nan X, Tate P, Li E, Bird A (1996) DNA methylation specifies chromosomal localization of MeCP2. Mol Cell Biol 16:414-421.
31. Nathwani AC, Tuddenham EG, Rangarajan S, Rosales C, McIntosh J, Linch DC, Chowdary P, Riddell A, Pie AJ, Harrington C, O'Beirne J, Smith K, Pasi J, Glader B, Rustagi P, Ng CY, Kay MA, Zhou J, Spence Y, Morton CL, Allay J, Coleman J, Sleep S, Cunningham JM, Srivastava D, Basner-Tschakarjan E, Mingozzi F, High KA, Gray JT, Reiss UM, Nienhuis AW, Davidoff AM (2011) Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med 365:2357-2365.
32. Nguyen MV, Du F, Felice CA, Shan X, Nigam A, Mandel G, Robinson JK, Ballas N (2012) MeCP2 is critical for maintaining mature neuronal networks and global brain anatomy during late stages of postnatal brain development and in the mature adult brain. J Neurosci 32:10021-10034.
33. O'Connor RD, Zayzafoon M, Farach-Carson MC, Schanen NC (2009) Mecp2 deficiency decreases bone formation and reduces bone volume in a rodent model of Rett syndrome. Bone 45:346-356.
34. Rastegar M, Hotta A, Pasceri P, Makarem M, Cheung AY, Elliott S, Park KJ, Adachi M, Jones FS, Clarke ID, Dirks P, Ellis J (2009) MECP2 isoform-specific vectors with regulated expression for Rett syndrome gene therapy. PloS one 4:e6810.
35. Reiss AL, Faruque F, Naidu S, Abrams M, Beaty T, Bryan RN, Moser H (1993) Neuroanatomy of Rett syndrome: a volumetric imaging study. Annal Neurol 34:227-234.
36. Robinson L, Guy J, McKay L, Brockett E, Spike RC, Selfridge J, De Sousa D, Merusi C, Riedel G, Bird A, Cobb SR (2012) Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome. Brain 135:2699-2710.
37. Skene PJ, Illingworth RS, Webb S, Kerr AR, James KD, Turner DJ, Andrews R, Bird AP (2010) Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol cell 37:457-468.
38. Sondhi D, Hackett NR, Peterson DA, Stratton J, Baad M, Travis KM, Wilson JM, Crystal RG (2007) Enhanced survival of the LINCL mouse following CLN2 gene transfer using the rh. 10 rhesus macaque-derived adeno-associated virus vector. Mol Ther 15:481-491.
39. Sondhi D, Peterson DA, Edelstein AM, del Fierro K, Hackett NR, Crystal RG (2008) Survival advantageofneonatal CNS gene transfer for late infantile neuronal ceroid lipofuscinosis. Exp Neurol 213:18-27.
40. Tudor M, Akbarian S, Chen RZ, Jaenisch R (2002) Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changesin the brain. Proc Natl Acad Sci USA 99:15536-15541.
41. Wither RG, Lang M, Zhang L, Eubanks JH (2013) Regional MeCP2 expression levels in the female MeCP2-deficient mouse brain correlate with specific behavioral impairments. Exp Neurol 239:49-59.